Skip to content

Regional Observatory on Metabolic Syndrome- LAZIO

Regional Observatory on Metabolic Syndrome in Italy- LAZIO

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00689455
Acronym
ORSA
Enrollment
1574
Registered
2008-06-03
Start date
2007-10-31
Completion date
2008-12-31
Last updated
2010-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

Metabolic Syndrome, Lipids, Waist Circumference

Brief summary

The aim of the study, is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* lipid profile in the last year * Signed informed consent

Exclusion criteria

* Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study * Pregnancy or breast feeding * Subject who are unwilling or unable to provide the informed consent

Design outcomes

Primary

MeasureTime frame
Prevalence of Metabolic Syndrome in Primary Care Population.At Visit

Secondary

MeasureTime frame
Concomitant presence of other CV risk factors.At Visit

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026